v3.23.1

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net loss	$ (119.9)	$ (97.0)
Loss from discontinued operations, net of tax	(27.4)	(7.8)
Loss from continuing operations, net of tax	(92.5)	(89.2)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation	13.3	10.9
Amortization	4.7	4.8
Provision for doubtful accounts	10.2	14.1
Provision for obsolescence	4.2	6.4
Share-based compensation	4.2	2.4
Foreign exchange (gains) losses	(5.6)	(7.3)
Deferred income taxes	5.0	(2.5)
Impairment loss on assets	9.1	0.0
Other	3.1	(0.6)
Changes in assets and liabilities:
Accounts receivable	4.7	(20.6)
Inventories	(21.0)	(33.1)
Prepaid expenses and other	(49.7)	9.4
Accounts payable and accrued liabilities	(43.2)	(65.4)
Income and other taxes	(6.2)	3.2
Noncurrent assets and liabilities	25.9	(0.9)
Net cash used by operating activities of continuing operations	(133.8)	(168.4)
Cash Flows from Investing Activities
Capital expenditures	(15.7)	(13.6)
Proceeds from disposal of assets	0.3	2.7
Net cash used by investing activities of continuing operations	(15.4)	(10.9)
Cash Flows from Financing Activities
Debt, net (maturities of three months or less)	41.6	86.8
Proceeds from debt	30.2	68.6
Repayment of debt	(1.7)	(18.9)
Repayment of debt to affiliates of Natura &Co	(52.5)	(10.7)
Repayment of debt from affiliates of Natura &Co	38.2	11.7
Settlement of derivative contracts	0.0	1.3
Net cash provided by financing activities of continuing operations	55.8	138.8
Net cash used by operating activities of discontinued operations	(24.6)	(5.6)
Net cash used by discontinued operations	(24.6)	(5.6)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash	(5.1)	3.1
Net (decrease) increase in cash and cash equivalents, and restricted cash	(123.1)	(43.0)
Cash and cash equivalents, and restricted cash at beginning of period	367.9	251.5
Cash and cash equivalents, and restricted cash at end of period	$ 244.8	$ 208.5

The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

AVON PRODUCTS INC 10-Q